AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AdaptHealth Corp. (NASDAQ:AHCO ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Christopher Joyce - General Counsel Stephen Griggs - CEO Joshua Parnes - President Jason Clemens - CFO Conference Call Participants Taji Phillips - Jefferies Pito Chickering - Deutsche Bank Kevin Caliendo - UBS Richard Close - Canaccord Genuity Joanna Gajuk - Bank of America Eric Coldwell - Robert W. Baird Whit Mayo - SVB Securities Operator Greetings, and welcome to AdaptHealth's Third Quarter 2022 Financial Results Conference Call.

AdaptHealth Corp. (AHCO) Q3 2022 Earnings Call Transcript

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -64.52% and 2.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates

AdaptHealth Corp. Announces Third Quarter 2022 Results and Updates 2022 Outlook

AdaptHealth Corp. Announces Third Quarter 2022 Earnings Release Date and Conference Call

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of the Company's long-term investors.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of AdaptHealth Corp. (AHCO) and Encourages Long-Term AHCO Investors to Contact the Firm

AdaptHealth Corp. (AHCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AdaptHealth Corp. (AHCO) Stock Jumps 5.2%: Will It Continue to Soar?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will host and webcast its 2022 Capital Markets Day beginning at 9:00 a.m. ET today. During the event, Chief Executive Officer Steve Griggs, President Josh Parnes, Chief Financial Officer Jason Clemens, and other members of AdaptHealth's sen

AdaptHealth Capital Markets Day to Highlight Progress Executing Strategy to Transform Healthcare by Keeping Patients Healthy at Home

AdaptHealth Corp. (NASDAQ:AHCO ) Q2 2022 Results Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Christopher Joyce - General Counsel Stephen Griggs - CEO Josh Parnes - President Jason Clemens - CFO Conference Call Participants Brian Tanquilut - Jefferies Kevin Caliendo - UBS Joanna Gajuk - Bank of America Philip Chickering - Deutsche Bank Whit Mayo - SVB Securities Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Operator Greetings, and welcome to the AdaptHealth Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

AdaptHealth Corp. (AHCO) CEO Stephen Griggs on Q2 2022 Results - Earnings Call Transcript

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -35.71% and 0.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Miss Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will host and webcast its first Capital Markets Day on Friday, September 16, 2022, at 9:00 a.m. Eastern Time. “We are excited to gather with investors and analysts to host our first Capital Markets Day this September,” said Steve Griggs, Ada

AdaptHealth Corp. to Host 2022 Capital Markets Day on September 16th

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2022. Second Quarter Results and Highlights AdaptHealth delivered net revenue and Adjusted EBITDA for the second quarter consistent with internal expectations, as it co

AdaptHealth Reports Second Quarter 2022 Results

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AdaptHealth Corp. (AHCO) Surges 8.3%: Is This an Indication of Further Gains?

Philadelphia, Pennsylvania--(Newsfile Corp. - July 23, 2022) - Kaskela Law LLC announces that it is investigating AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) on behalf of the Company's long-term investors.Recently a securities fraud complaint was filed against AdaptHealth on behalf of certain investors who purchased shares of AdaptHealth's common stock between November 8, 2019 and July 16, 2021.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of AdaptHealth Corp. (AHCO) and Encourages Long-Term Investors to Contact the Firm

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2022 financial results before the opening of the financial markets on Tuesday, August 9, 2022. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts

AdaptHealth Corp. Announces Second Quarter 2022 Earnings Release Date and Conference Call

PLYMOUTH MEETING, Pa--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, at 10:00 am ET. A live webcast and replay will be accessible th

AdaptHealth to Participate in Jefferies Healthcare Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 on Wednesday, May 25, at 10:00 am ET. A live webcast and replay will be access

AdaptHealth to Participate in UBS Global Healthcare Conference 2022

AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2022 Results Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Christopher Joyce - General Counsel Stephen Griggs - CEO Joshua Parnes - President Jason Clemens - CFO Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - BofA Securities Andrea Alfonso - UBS Philip Chickering - Deutsche Bank Mathew Blackman - Stifel Whit Mayo - SVB Leerink Eric Coldwell - Robert W. Baird Operator Greetings, and welcome to the AdaptHealth First Quarter 2022 Financial Results Conference Call.

AdaptHealth Corp. (AHCO) CEO Stephen Griggs on Q1 2022 Results - Earnings Call Transcript

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on Tuesday, May 17, at 10:30 am ET. A live webcast and replay will be acces

AdaptHealth to Participate in RBC Capital Markets 2022 Global Healthcare Conference

The stock spiked following the company's first-quarter earnings release.

Why AdaptHealth's Shares Jumped 30% on Tuesday

AdaptHealth Corp (NASDAQ: AHCO) says it delivered solid Q1 net revenue and Adjusted EBITDA as it began to overcome ongoing challenges resulting from shortages of CPAP equipment. Net revenue increased 46.5% to $706.2 million, beating the consensus of $651.46 million.

Here's Why AdaptHealth Shares Are Soaring Today

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -109.52% and 9.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2022, and announced the authorization of a share repurchase program for up to $200 million. First Quarter Results and Highlights AdaptHealth delivered solid net revenue

AdaptHealth Reports First Quarter 2022 Results, Updates 2022 Guidance, and Announces $200 Million Share Repurchase Program

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth to Participate in BofA Securities 2022 Healthcare Conference

AdaptHealth to Participate in BofA Securities 2022 Healthcare Conference

There's a reason why it's so cheap, but it isn't a deal breaker.

Love Dirt-Cheap Growth Stocks? Check Out This Under-The-Radar Buy

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2022 financial results before the opening of the financial markets on Tuesday, May 10, 2022. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts an

News for AdaptHealth Corp Stock (AHCO)